DMAA
Drugs Made In·NASDAQ
--
--(--)
--
--(--)
5.44 / 10
Netural
The stock demonstrates mixed technical signals with an overall technical score of 5.44/10. Bullish indicators include MACD Death Cross and Marubozu White, while MACD Golden Cross show concerning signals. The technical outlook appears neutral with watchful bias based on current momentum patterns.
Analysis Checks(2/3)
MACD Death Cross
Score6.29/10
Win Rate61.11%
Hist. Signals18
Avg Return0.04%
Score6.29/10
Win Rate61.11%
Hist. Signals18
Avg Return0.04%
Marubozu White
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.05%
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.05%
MACD Golden Cross
Score2.98/10
Win Rate47.37%
Hist. Signals19
Avg Return0.02%
Score2.98/10
Win Rate47.37%
Hist. Signals19
Avg Return0.02%
MACD Death Cross
Score6.29/10
Win Rate61.11%
Hist. Signals18
Avg Return0.04%
Score6.29/10
Win Rate61.11%
Hist. Signals18
Avg Return0.04%
MACD Golden Cross
Score2.98/10
Win Rate47.37%
Hist. Signals19
Avg Return0.02%
Score2.98/10
Win Rate47.37%
Hist. Signals19
Avg Return0.02%
Marubozu White
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.05%
Score7.05/10
Win Rate63.46%
Hist. Signals52
Avg Return0.05%
Technical Analysis of DMAA?
- DMAA presents a Netural setup with a Technical Score of 5.44/10. Key technical indicators highlight an RSI of 59.50 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 10.47. Traders should monitor key support at 10.52 and resistance at 10.52.
